|Podcasts|February 10, 2012
Podcast: Key Business Considerations for Growing BioPharm Product Pipeline
BioPharm International interviews Tarja Mottram, CEO of Action for Results, on the marriage of science and business to ensure sustainable growth. Posted Feb. 2012.
Advertisement
In this first intervew with BioPharm International, Tarja Mottram, CEO of Action for Results, discusses some of the deeper business considerations for companies planning to grow with a pipeline or portfolio. Posted Feb. 2012.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
3
BioPharma By The Numbers: Batch Failures in Biopharma Manufacturing
4
New Cord Blood Stem Cell Approval Alters Biopharma Manufacturing Priorities
5
